Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener Medizinische Wochenschrift
Erschienen in:

01.01.2014 | main topic

Alcohol and bone

verfasst von: Assoc. Prof. Dr. Peter Mikosch, MD

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 1-2/2014

Einloggen, um Zugang zu erhalten

Summary

Alcohol is widely consumed across the world in different cultural and social settings. Types of alcohol consumption differ between (a) light, only occasional consumption, (b) heavy chronic alcohol consumption, and (c) binge drinking as seen as a new pattern of alcohol consumption among teenagers and young adults. Heavy alcohol consumption is detrimental to many organs and tissues, including bones. Osteoporosis is regularly mentioned as a secondary consequence of alcoholism, and chronic alcohol abuse is established as an independent risk factor for osteoporosis. The review will present the different mechanisms and effects of alcohol intake on bone mass, bone metabolism, and bone strength, including alcoholism-related “life-style factors” such as malnutrition, lack of exercise, and hormonal changes as additional causative factors, which also contribute to the development of osteoporosis due to alcohol abuse.
Vorheriger Artikel Alkohol induzierte kognitive Dysfunktion
Nächster Artikel Was Ethanolmetabolite als Biomarker über Alkoholkonsum aussagen
Literatur
1.
Frost M, Wraae K, Gudex C, et al. Diseases in elderly men: underreporting and underdiagnosis. Age Ageing. 2012;41:177–83. doi:10.1093/ageing/afr153.CrossRefPubMed
2.
Gómez Navarro R. [Prevalence of risk factors for fragility fracture in men aged 40 to 90 years of a Spanish basic Rural Health Area]. Rev Esp Salud Publica. 2011;85:491–8.CrossRefPubMed
3.
Vestergaard P, Rejnmark L, Mosekilde L. Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark. Scand J Public Health. 2006;34:371–7.CrossRefPubMed
4.
Audran M, Cortet B. Prevalence of osteoporosis in male patients with risk factors. Presse Med. 2011;40:e489–98. doi:10.1016/j.lpm.2011.08.002.CrossRefPubMed
5.
Legroux-Gerot I, Blanchaert F, Solau-Gervais E, et al. Causes of osteoporosis in males. A review of 160 cases. Rev Rhum Engl Ed. 1999;66:404–9.PubMed
6.
7.
Suh KT, Kim SW, Roh HL, et al. Decreased osteogenic differentiation of mesencymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Relat Res. 2005;431:220–5.CrossRefPubMed
8.
Wang Y, Li Y, Mao K, et al. Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop Relat Res. 2003;410:213–24.CrossRefPubMed
9.
Friday KE, Howard GA. Ethanol inhibits human bone cell proliferation and function in vitro. Metabolism. 1991;40:562–5.CrossRefPubMed
10.
Chavassieux P, Serre CM, Vergnaud P, et al. In vitro evaluation of dose-effects of ethanol on human osteoblastic cells. Bone Miner. 1993;22:95–103.CrossRefPubMed
11.
Dai J, Lin D, Zhang J, et al. Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest. 2000;106:887–95.PubMedCentralCrossRefPubMed
12.
Klein RF, Fausti KA, Carlos AS. Ethanol inhibits human osteoblastic cell proliferation. Alcohol Clin Exp Res. 1996; 20:572–8.CrossRefPubMed
13.
Maurel DB, Boisseau N, Benhamou CL, Jaffre C. Alcohol and bone: review of dose effects and mechanisms. Osteoporos Int. 2012;23:1–16.CrossRefPubMed
14.
García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, et al. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol. 2006;41:261–6.CrossRefPubMed
15.
Fabrega E, Orive A, Garcia-Suarez C, et al. Osteoprotegerin and RANKL in alcoholic liver cirrhosis. Liver Int. 2005;25:305–10.CrossRefPubMed
16.
Santori C, Ceccanti M, Diacinti D, et al. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol. J Endocrinol Invest. 2008;31:321–6.PubMed
17.
González-Reimers E, Martín-González C, de la Vega-Prieto MJ, et al. Serum sclerostin in alcoholics: a pilot study. Alcohol Alcohol. 2013;48:278–82. doi:10.1093/alcalc/ags136.CrossRefPubMed
18.
Chen JR, Haley RL, Hidestrand M, et al. Ertradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB in osteoblasts. J Pharmacol Exp Ther. 2006;319:1182–90.CrossRefPubMed
19.
20.
Chen JR, Badger TM, Nagaragian S, Ronis MJJ. Inhibition of reactive oxygen species generation and downstream activation of the ERK/STAT3/RANKL-signaling cascade to osteoblasts accounts for the protective effects of estradiol on ethanol-induced bone loss. J Pharmacol Exp Ther. 2008;324:50–9.CrossRefPubMed
21.
Kim MJ, Shim MS, Kim MK, et al. Effect of chronic alcohol ingestion on bone mineral density in males without liver cirrhosis. Korean J Intern Med. 2003;18:174–80.PubMed
22.
Wezeman FH, Emanuele MA, Emanuele NV, et al. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength. Alcohol Clin Exp Res. 1999;23:1534–42.CrossRefPubMed
23.
Hogan HA, Sampson HW, Cashier E, Ledoux N. Alcohol consumption by young actively growing rats: a study of cortical bone histomorphometry and mechanical properties. Alcohol Clin Exp Res. 1997;21:809–16.PubMed
24.
Mercer KE, Wynne RA, Lazarenko OP, et al. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther. 2012;343:401–12. doi:10.1124/jpet.112.197ß38.
25.
Nyquist F, Düppe H, Obrant KJ, et al. Effects of alcohol on bone mineral and mechanical properties of bone in male rats. Alcohol Alcohol. 2002;37:21–4.CrossRefPubMed
26.
Sibonga JD, Iwaniec UT, Shogren KL, et al. Effects of parathyroid hormone (1–34) on tibia in the adult rat model for chronic alcohol abuse. Bone. 2007;40:1013–20.CrossRefPubMed
27.
Wezeman FH, Juknelis D, Frost N, Callarci JJ. Spine bone mineral density and vertebral body height are altered by alcohol consumption in growing male and female rats. Alcohol. 2003;31:87–92.PubMedCentralCrossRefPubMed
28.
Hogan HA, Groves JA, Sampson HW. Long-term alcohol consumption in the rat affects femur cross-sectional geometry and bone tissue material properties. Alcohol Clin Exp Res. 1999;23:1825–33.CrossRefPubMed
29.
Hogan HA, Argueta F, Moe L, et al. Adult-onset alcohol consumption induces osteopenia in female rats. Alcohol Clin Exp Res. 2001;25:746–54.CrossRefPubMed
30.
Trevisiol CH, Turner RT, Pfaff JE, et al. Impaired osteoinduction in a rat model for chronic alcohol abuse. Bone. 2007;41:175–80.
31.
Lauing K, Himes R, Rachwalski M, et al. Binge alcohol treatment of adolescent rats followed by alcohol abstinence is associated with site-specific differences in bone loss and incomplete recovery of bone mass and strength. Alcohol. 2008;42:649–56. doi:10.1016/j.alcohol.2008.08.005.PubMedCentralCrossRefPubMed
32.
Shimizu Y, Sakai A, Menuki K, et al. Reduced bone formation in alcohol-induced osteopenia is associated with elevated p21 expression in bone marrow cells in aldehyde dehydrogenase 2-disrupted mice. Bone. 2011;48:1075–86.CrossRefPubMed
33.
Callaci JJ, Himes R, Lauing K, et al. Binge alcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone. Calcif Tissue Int. 2009;84:474–84.
34.
Elmali N, Ertem K, Ozen S, et al. Fracture healing and bone mass in rats fed on liquid diet containing ethanol. Alcohol Clin Exp Res. 2002;26:509–13.CrossRefPubMed
35.
Chakkalakal DA, Novak JR, Fritz ED, et al. Chronic ethanol consumption results in deficient bone repair in rats. Alcohol Alcohol. 2002;37:13–20.CrossRefPubMed
36.
Chakkalakal DA, Novak JR, Fritz ED, et al. Inhibition of bone repair in a rat model for chronic and excessive alcohol consumption. Alcohol. 2005;36:201–14.CrossRefPubMed
37.
Shankar K, Hidestrand M, Liu X, et al. Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats. J Bone Miner Res. 2008;23:338–49.CrossRefPubMed
38.
Malik P, Gasser RW, Kemmler G, et al. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res. 2009;33:375–81.CrossRefPubMed
39.
Nelson RE, Nebeker JR, Sauer BC, Lafleur J. Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone. 2012;50:983–8. doi:10.1016/j.bone.2011.11.014.CrossRefPubMed
40.
Malik P. Alkoholinduzierte Reaktion der Knochenmineraldichte: eine Übersicht. J Miner Stoffwechs. 2008;15:123–8.
41.
Duggan SN, O’Sullivan M, Hamilton S, et al. Patients with chronic pancreatitis are at increased risk for osteoporosis. Pancreas. 2012;41:1119–24. doi:10.1097/MPA.0b013e31824abb4d.CrossRefPubMed
42.
Laitinen K, Välimäki M, Lamberg-Allardt C, et al. Deranged vitamin D metabolism but normal bone mineral density in Finnish noncirrhotic male alcoholics. Alcohol Clin Exp Res. 1990;14:551–6.CrossRefPubMed
43.
Carey EJ, Balan V, Kremers WK, et al. Osteopenia and osteoporosis in patients with end stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem. Liver Transpl. 2003;9:1166–73.CrossRefPubMed
44.
Garcia-Valdecasas-Campelo E, Gonzalez-Reimers E, Santoria-Fernandez F, et al. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol. 2006;41:261–6.CrossRefPubMed
45.
Gonzalez-Calvín JL, Garcia-Sanchez A, Bellot V, et al. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol. 1993;28:571–9.PubMed
46.
Diamond T, Striel D, Lunzer M, et al. Osteoporosis and skeletal fractures in chronic liver disease. Gut. 1990;31:82–7.CrossRefPubMed
47.
Leslie WD, Bernstein CN, Leboff MS; American Gastroenterological Association Clinical Practice Comitee. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology. 2003;125:941–66.CrossRefPubMed
48.
Iwaniec UT, Wronski TJ, Turner RT. Histological analysis of bone. Methods Mol Biol. 2008;447:325–41.CrossRefPubMed
49.
Berg KM, Kunins HV, Jackson JL, et al. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med. 2008;121:406–18. doi:10.1016/j.amjmed.2007.12.012.PubMedCentralCrossRefPubMed
50.
Kouda K, Iki M, Fujita Y, et al. Alcohol intake and bone status in elderly Japanese men: baseline data from the Fujiwara-kyo osteoporosis risk in men (FORMEN) study. Bone. 2011;49:275–80.CrossRefPubMed
51.
González-Reimers E, Alvisa-Negrín J, Santolaria-Fernández F, et al. Prognosis of osteopenia in chronic alcoholics. Alcohol. 2011;45:227–38. doi:10.1016/j.alcohol.2010.09.002.CrossRefPubMed
52.
Wosje KS, Kalkwarf HJ. Bone density in relation to alcohol intake among men and women in the United States. Osteoporos Int. 2007;18:391–400.CrossRefPubMed
53.
Laitinen K, Lamberg-Allardt C, Tunninen R, et al. Bone mineral density and abstention-induced changes in bone and mineral metabolism in noncirrhotic male alcoholics. Am J Med. 1992;93:642–50.CrossRefPubMed
54.
55.
George J, Ganesh HK, Acharya S, et al. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009;15:3516–22.CrossRefPubMed
56.
Chen CC, Wang SS, Jeng FS, Lee SD. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol. 1996;11:417–21.CrossRefPubMed
57.
Díez-Ruiz A, García-Saura PL, García-Ruiz P, et al. Bone mineral density, bone turnover markers and cytokines in alcohol-induced cirrhosis. Alcohol Alcohol. 2010; 45:427–30.CrossRefPubMed
58.
Patri B, Le Charpentier Y, Guéris J, et al. [Vitamin D, parathormone, calcitonin and bone histomorphometry in patients with cirrhosis]. Rev Rhum Mal Osteoartic. 1978;45:631–40.PubMed
59.
Alvisa-Negrín J, González-Reimers E, Santolaria-Fernández F, et al. Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol Alcohol. 2009;44:468–75.CrossRefPubMed
60.
61.
Mobarhan SA, Russell RM, Recker RR, et al. Metabolic bone disease in alcoholic cirrhosis: a comparison of the effect of vitamin D2, 25-hydroxyvitamin D, or supportive treatment. Hepatology. 1984;4:266–73.CrossRefPubMed
62.
Monegal A, Navasa M, Guañabens N, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int. 1997;60:148–54.CrossRefPubMed
63.
Hippisley Cox J, Coupland C. Predicting risk of osteoporotic fractures in men and women in England and Wales: prospective derivation and validation of QFracture Scores. BMJ. 2009;339:b4229.
64.
Mikosch P, Hughes D. An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr. 2010;160:609–24. doi:10.1007/s10354-010-0841-y.CrossRefPubMed
65.
Roach R, Miller D, Driffiths D. Multifocal osteonecrosis predominantly affecting the knees secondary to chronic alcohol ingestion: a case report and review. Acta Orthop Belg. 2006;72:234–6.PubMed
66.
Shigemura T, Nakamura J, Kishida S, et al. The incidence of alcohol-associated osteonecrosis of the knee is lower than the incidence of steroid-associated osteonecrosis of the knee: an MRI study. Rheumatology (Oxford). 2012;51:701–6. doi:10.1093/rheumatology/ker426.CrossRef
67.
Weinstein RS, Nicholas RW, Manolagas SC. Apoptosis of osteocytes in glucocorticoid-induced ostenecrosis of the hip. J Clin Endocrinol Metab. 2000;85:2907–12.PubMed
68.
Kuga Y. Factors associated with osteonecrosis in the femoral head in chronic alcoholism. Kurume Med J. 2000;47:147–9.CrossRefPubMed
69.
Delling G. Pathophysiology of femoral head necrosis. Orthopade. 2007;36:404, 406–8, 410–3.CrossRefPubMed
70.
Kang JS, Park S, Song JH, et al. Prevalence of osteonecrosis of the femoral head: a nationwide epidemiological analysis in Korea. J Arthroplasty. 2009;24:1178–83. doi:10.1016/j.arth.2009.05.022.CrossRefPubMed
71.
Kukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715–24. doi:10.1007/s11999-010-1292-x.CrossRef
72.
Iwaniec UT, Trevisiol CH, Maddalozzo GF, et al. Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse. Bone. 2008;42:695–701. doi:10.1016/j.bone.2007.12.221.PubMedCentralCrossRefPubMed
73.
Tucker KL, Jugdaohsingh R, Powell JJ, et al. Effects of beer, wine, and liquor intakes on bone mineral density in older men and women. Am J Clin Nutr. 2009;89:1188–96.CrossRefPubMed
74.
Williams FM, Cherkas LF, Spector TD, MacGregor AJ. The effect of moderate alcohol consumption on bone mineral density: a study of female twins. Ann Rheum Dis. 2005;64:309–10.CrossRefPubMed
75.
Meadows ES, Mitchell BD, Bolge SC, et al. Factors associated with treatment of women with osteoporosis or osteopenia from a national survey. BMC Womens Health. 2012;12:1. doi:10.1186/1472-6874-12-1.PubMedCentralCrossRefPubMed
76.
Wezeman FH, Emanuele MA, Moskal SF, et al. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat. J Bone Miner Res. 2000;15:2033–41.CrossRefPubMed
Metadaten
Titel
Alcohol and bone
verfasst von
Assoc. Prof. Dr. Peter Mikosch, MD
Publikationsdatum
01.01.2014
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 1-2/2014
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-013-0258-5

Weitere Artikel der Ausgabe 1-2/2014

Was Ethanolmetabolite als Biomarker über Alkoholkonsum aussagen

  • themenschwerpunkt

Alkohol induzierte kognitive Dysfunktion

  • themenschwerpunkt

Ethik und ärztliches Ethos im Medizinstudium und im Gesundheitswesen

  • originalarbeit

Management bei schwerer alkoholischer Hepatitis

  • themenschwerpunkt

Alcohol induced disorders

  • editorial